GlassScriptPhysician profile
Lisa M Cunningham
NPI 1033534284
$12,621.93
in general payments reported to CMS, 2019-2025
39 companies · $8,192 in 2025
The $8,192 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2022: $723 · 2023: $1,490 · 2024: $1,974 · 2025: $8,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,616 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,673 · Consulting Fee: $2,060 · Travel and Lodging: $1,121 · Education: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,615.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,673.00 |
| Consulting Fee | $2,060.00 |
| Travel and Lodging | $1,120.82 |
| Education | $186.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $4,443.84 | 2022-2025 | |
| Janssen Biotech, INC. | $1,984.99 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Medtronic, INC. | $1,223.74 | 2021-2025 | Interstim |
| Janssen Global Services, LLC | $1,160.00 | 2025 | |
| Myriad Genetic Laboratories, INC. | $747.41 | 2022-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $504.71 | 2022-2025 | Provenge |
| Endo Pharmaceuticals INC. | $427.39 | 2022-2024 | Aveed, Xiaflex |
| Procept Biorobotics Corporation | $298.77 | 2025 | |
| Abbvie INC. | $252.21 | 2023-2025 | |
| Tempus Ai, INC | $129.91 | 2025 | Xt Cdx |
| Amgen INC. | $124.99 | 2024 | |
| Myovant Sciences INC. | $102.46 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $96.13 | 2021-2022 | |
| Johnson & Johnson Health Care Systems INC. | $94.55 | 2022 | |
| Sun Pharmaceutical Industries INC. | $94.45 | 2021-2025 | Yonsa |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $89.11 | 2022-2025 | |
| Astellas Pharma US INC | $86.99 | 2023 | |
| Sumitomo Pharma America, INC. | $81.64 | 2023 | Orgovyx |
| Endo USA, INC. | $70.16 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $62.75 | 2021-2025 | Urolift |
| Ethicon US, LLC | $53.55 | 2022-2024 | Echelon; Endopath, Harmonic |
| Ferring Pharmaceuticals INC. | $41.81 | 2025 | Adstiladrin |
| Coloplast Corp | $39.66 | 2022 | |
| Accord Healthcare, INC. | $38.50 | 2023-2024 | |
| Verity Pharmaceuticals INC. | $37.96 | 2023-2024 | Trelstar |
| Janssen Scientific Affairs, LLC | $37.87 | 2023 | Erleada |
| Bioprotect Medical, INC. | $34.93 | 2024-2025 | Bioprotect Balloon Implant System |
| Blue Earth Diagnostics | $33.30 | 2023 | |
| Antares Pharma, INC. | $31.68 | 2021-2022 | |
| Eagle Pharmaceuticals, INC. | $26.46 | 2024 | |
| Novo Nordisk INC | $23.33 | 2025 | Ozempic, Rybelsus |
| C. R. Bard, INC. & Subsidiaries | $23.32 | 2021 | |
| Axonics, INC. | $21.51 | 2022 | |
| Calyxo, INC. | $18.98 | 2025 | Cvac Aspiration System |
| Astrazeneca Pharmaceuticals LP | $18.60 | 2023 | Lynparza |
| Olympus America INC. | $18.02 | 2023 | Itind System |
| Telix Pharmaceuticals | $15.57 | 2025 | Illuccix |
| Boston Scientific Corporation | $15.48 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.